Pro-Avandia FDA Panelist Is Paid GSK Speaker
One of the U.S. Food and Drug Administration's advisory panelists who voted to keep the controversial diabetes drug Avandia on the market reportedly is also a paid speaker for the manufacturer,...To view the full article, register now.
Already a subscriber? Click here to view full article